Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5230)
All Articles published online
|
Aug 15, 2010 (publication date) through Nov 13, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Koukourakis GV, Zacharias G, Tsalafoutas J, Theodoridis D, Kouloulias V. Capecitabine for locally advanced and metastatic colorectal cancer: A review. World J Gastrointest Oncol 2010; 2(8): 311-321 [PMID: 21160892 DOI: 10.4251/wjgo.v2.i8.311] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v2/i8/311.htm |
| Number | Citing Articles |
| 1 |
Gilad Nahari, Ori Braitbard, Liraz Larush, Jacob Hochman, Edit Y. Tshuva. Effective Oral Administration of an Antitumorigenic Nanoformulated Titanium Complex. ChemMedChem 2021; 16(1): 108 doi: 10.1002/cmdc.202000384
|
| 2 |
Leni van Doorn, Niels Heersche, Femke M. de Man, Peter de Bruijn, Ivo Bijl, Esther Oomen‐de Hoop, Ferry A. L. M. Eskens, Ate van der Gaast, Ron H. J. Mathijssen, Sander Bins. Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial. Clinical Pharmacology & Therapeutics 2022; 111(2): 455 doi: 10.1002/cpt.2444
|
| 3 |
Lukas Schlager, Katharina Wöran, Helena Luhn, Anton Stift, Felix Harpain. A Case Report of Capecitabine-Associated Bowel Inflammation With a Novel Mutation of the DPYD Gene. AJSP: Reviews and Reports 2020; 25(4): e8 doi: 10.1097/PCR.0000000000000396
|
| 4 |
Panattharin Lerdkiattikorn, Usa Chaikledkaew, Wirote Lausoontornsiri, Somjin Chindavijak, Thirawud Khuhaprema, Narisa Tantai, Yot Teerawattananon. Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand. Expert Review of Pharmacoeconomics & Outcomes Research 2015; 15(4): 687 doi: 10.1586/14737167.2015.972379
|
| 5 |
Thulani H. Senanayake, Galya Warren, Xin Wei, Serguei V. Vinogradov. Application of activated nucleoside analogs for the treatment of drug-resistant tumors by oral delivery of nanogel-drug conjugates. Journal of Controlled Release 2013; 167(2): 200 doi: 10.1016/j.jconrel.2013.01.020
|
| 6 |
Sonia Pandey, S. M. Vijayendra Swamy, Arti Gupta, Akshay Koli, Swagat Patel, Furqan Maulvi, Bhavin Vyas. Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon. Journal of Microencapsulation 2018; 35(3): 259 doi: 10.1080/02652048.2018.1465138
|
| 7 |
Akhil Santhosh, Akash Kumar, Raja Pramanik, Ajay Gogia, Chandra Prakash Prasad, Ishaan Gupta, Nishkarsh Gupta, Winson Y. Cheung, Ravindra Mohan Pandey, Atul Sharma, Atul Batra. Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study). Trials 2022; 23(1) doi: 10.1186/s13063-022-06353-2
|
| 8 |
Emilio P. Araujo-Mino, Yehuda Z. Patt, Cristina Murray-Krezan, Joshua A. Hanson, Pranshu Bansal, Ben J. Liem, Ashwani Rajput, M. Houman Fekrazad, Glenory Heywood, Fa Chyi Lee. Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer. The Oncologist 2018; 23(1): 2 doi: 10.1634/theoncologist.2017-0474
|
| 9 |
D. Greto, F. Paiar, C. Saieva, A. Galardi, M. Mangoni, L. Livi, B. Agresti, D. Franceschini, P. Bonomo, V. Scotti, B. Detti, F. Tonelli, A. Valeri, L. Messerini, G. Biti. Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a singleinstitution experience. La radiologia medica 2013; 118(4): 570 doi: 10.1007/s11547-012-0909-4
|
| 10 |
Frederik E. Stuurman, Bastiaan Nuijen, Jos H. Beijnen, Jan H. M. Schellens. Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement. Clinical Pharmacokinetics 2013; 52(6): 399 doi: 10.1007/s40262-013-0040-2
|
| 11 |
P.H. Rajasree, Willi Paul, Chandra P. Sharma, Riyaz Ali M. Osmani, Umme Hani, Atul Srivastava. Eudragit encapsulated cationic poly (lactic-co-glycolic acid) nanoparticles in targeted delivery of capecitabine for augmented colon carcinoma therapy. Journal of Drug Delivery Science and Technology 2018; 46: 302 doi: 10.1016/j.jddst.2018.05.025
|
| 12 |
Bhavesh D. Kevadiya, Shiva Shankaran Chettiar, Shalini Rajkumar, Hari C. Bajaj, Harshad Brahmbhatt, Jayesh C. Chaudhari, Rahul P. Thumbar, Devendrasinh Jhala, Mandava V. Rao. Evaluation of Montmorillonite/Poly (L-Lactide) microcomposite spheres as ambidextrous reservoirs for controlled release of Capecitabine (Xeloda) and assessment of cell cytotoxic and oxidative stress markers. Composites Science and Technology 2014; 90: 193 doi: 10.1016/j.compscitech.2013.11.003
|
| 13 |
Fang-Fang Yuan, Rong-Rong Zhang, Xiaoli Ma, Jian Yang, Yan-Ping Huang, Zhao-Sheng Liu. Cooperation effect of 4-vinylbenzeneboronic acid/methacrylic acid on affinity of capecitabine imprinted polymer for drug carrier. European Journal of Pharmaceutical Sciences 2020; 154: 105476 doi: 10.1016/j.ejps.2020.105476
|
| 14 |
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence. 2022; : 125 doi: 10.1007/978-3-031-10839-6_5
|
| 15 |
Kavya Karthikeyan, K V Sameera, Shintu Shaji, M Ann C Swetha, C S Madhu. Capecitabine induced Steven–Johnson syndrome: A rare case report. Journal of Oncology Pharmacy Practice 2022; 28(1): 250 doi: 10.1177/10781552211027945
|
| 16 |
Li‐Ping Zhang, Chun‐E Mo, Yan‐Ping Huang, Zhao‐Sheng Liu. Preparation of Liquid Crystalline Molecularly Imprinted Polymer Coated Metal Organic Framework for Capecitabine Delivery. Particle & Particle Systems Characterization 2019; 36(1) doi: 10.1002/ppsc.201800355
|
| 17 |
Y. Miki, K. Maeda, M. Hosono, H. Nagahara, K. Hirakawa, Y. Shimatani, S. Tsutsumi, Y. Miki. Neoadjuvant capecitabine, bevacizumab and radiotherapy for locally advanced rectal cancer: results of a single-institute Phase I study. Journal of Radiation Research 2014; 55(6): 1171 doi: 10.1093/jrr/rru063
|